Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - anpec is indicated for:,-hypertension,-angina of effort,-angina at rest,-vasospastic angina (including prinzmetal?s variant angina),-tachyarrhythmias including paroxysmal supra-ventricular tachycardia,-atrial fibrillation with rapid ventricular response,-atrial flutter with rapid ventricular response

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - verapamil hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; hypromellose; sodium lauryl sulfate; macrogol 6000; purified talc; titanium dioxide - anpec is indicated for:,-hypertension,-angina of effort,-angina at rest,-vasospastic angina (including prinzmetal?s variant angina),-tachyarrhythmias including paroxysmal supra-ventricular tachycardia,-atrial fibrillation with rapid ventricular response,-atrial flutter with rapid ventricular response

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fluvoxamine maleate, quantity: 100 mg - tablet, film coated - excipient ingredients: titanium dioxide; mannitol; macrogol 8000; magnesium stearate; hyetellose; iron oxide red; iron oxide yellow; iron oxide black - indicated for the treatment of major depression in adults. indicated for the treatment of obsessive compulsive disorder in children aged 8 years of age and older, adolescents, and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fluvoxamine maleate, quantity: 50 mg - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 8000; magnesium stearate; mannitol; hyetellose; iron oxide yellow - indicated for the treatment of major depression in adults. indicated for the treatment of obsessive compulsive disorder in children aged 8 years of age and older, adolescents, and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 100 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; sodium stearylfumarate; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide - movox (fluvoxamine maleate) is indicated for the treatment of major depression in adults. movox (fluvoxamine maleate) is also indicated for the treatment of obsessive compulsive disorder (ocd) in both children aged 8 years and older, adolescent, and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 50 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide; sodium stearylfumarate - movox (fluvoxamine maleate) is indicated for the treatment of major depression in adults. movox (fluvoxamine maleate) is also indicated for the treatment of obsessive compulsive disorder (ocd) in both children aged 8 years and older, adolescent, and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fluvoxamine maleate, quantity: 50 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; sodium stearylfumarate; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide - luvox (fluvoxamine maleate) is indicated for the treatment of: major depression in adults, and obsessive compulsive disorder (ocd) in both children aged 8 years and older and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate, quantity: 1148 mg (equivalent: amoxicillin, qty 1000 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate type a; purified talc; microcrystalline cellulose; hypromellose; titanium dioxide; povidone; magnesium stearate - for the treatment of acute exacerbation of chronic bronchitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fluvoxamine maleate, quantity: 100 mg - tablet, film coated - excipient ingredients: mannitol; maize starch; pregelatinised potato starch; sodium stearylfumarate; colloidal anhydrous silica; hypromellose; macrogol 6000; purified talc; titanium dioxide - * for the treatment of major depression. * for the treatment of obsessive compulsive disorder (ocd) in children aged 8 years and older and adults.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluvoxamine maleate, quantity: 100 mg - tablet, film coated - excipient ingredients: pregelatinised potato starch; titanium dioxide; mannitol; maize starch; macrogol 6000; sodium stearylfumarate; purified talc; hypromellose; colloidal anhydrous silica - luvox (fluvoxamine maleate) is indicated for the treatment of: major depression in adults. it is also indicated for the treatment of obsessive compulsive disorder (ocd) in children aged 8 years of age and older, adolescents and adults.